Your browser doesn't support javascript.
loading
TPI1 activates the PI3K/AKT/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5.
Jin, Xiaoying; Wang, Dandan; Lei, Mengxia; Guo, Yan; Cui, Yuqing; Chen, Fengzhi; Sun, Weiling; Chen, Xuesong.
Afiliación
  • Jin X; The Fourth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150040, China.
  • Wang D; The Fourth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150040, China.
  • Lei M; The Fourth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150040, China.
  • Guo Y; The Fourth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150040, China.
  • Cui Y; The Fourth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150040, China.
  • Chen F; The Fourth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150040, China.
  • Sun W; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150040, China. sunweiling@hrbmu.edu.cn.
  • Chen X; The Fourth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150040, China. cxs1978@ems.hrbmu.edu.cn.
J Transl Med ; 20(1): 191, 2022 05 04.
Article en En | MEDLINE | ID: mdl-35509067
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Fosfatidilinositol 3-Quinasas Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Transl Med Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Fosfatidilinositol 3-Quinasas Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Transl Med Año: 2022 Tipo del documento: Article País de afiliación: China